Exudative vitreoretinopathy 4: genes and variants

Explore variant evidence for Exudative vitreoretinopathy 4 across 1 analyzed protein (LRP5). Linked ClinVar records include 17 pathogenic or likely pathogenic variants, 179 variants of uncertain significance and 28 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.

Data updated 2026-11-05. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Exudative vitreoretinopathy 4

Weakly linked (only a few uncertain records): CTNNB1.

ClinVar pathogenic and likely pathogenic variants linked to Exudative vitreoretinopathy 4

VariantPositionProtein partClinical label
LRP5 G404R404LDL-receptor class B 6Pathogenic / likely pathogenic (★★)
LRP5 D424N424LDL-receptor class B 6Pathogenic / likely pathogenic (★★)
LRP5 R494Q494LDL-receptor class B 8Pathogenic / likely pathogenic (★★)
LRP5 D1288G1288LDL-receptor class A 1Pathogenic / likely pathogenic (★★)
LRP5 T1041M1041LDL-receptor class B 17Pathogenic / likely pathogenic (★★)
LRP5 N198S198LDL-receptor class B 3Pathogenic / likely pathogenic (★★)
LRP5 R229W229LDL-receptor class B 4Pathogenic / likely pathogenic (★★)
LRP5 R1188W1188LDL-receptor class B 20Pathogenic / likely pathogenic (★★)
LRP5 D1363N1363LDL-receptor class A 3Pathogenic / likely pathogenic (★★)
LRP5 A422T422LDL-receptor class B 6Pathogenic / likely pathogenic (★)
LRP5 G876S876LDL-receptor class B 15Pathogenic / likely pathogenic (★)
LRP5 C926Y926EGF-like 3Pathogenic / likely pathogenic (★)
LRP5 C306Y306EGF-like 1Pathogenic / likely pathogenic (★)
LRP5 D862V862YWTD 11Pathogenic / likely pathogenic (★)
LRP5 P1026R1026LDL-receptor class B 16Pathogenic / likely pathogenic (★)
LRP5 L145F145LDL-receptor class B 2Pathogenic / likely pathogenic
LRP5 C1305Y1305LDL-receptor class A 2Pathogenic / likely pathogenic

Uncertain variants prioritized for review in Exudative vitreoretinopathy 4

VariantPositionProtein partClinical labelEvidence
LRP5 C1305R1305LDL-receptor class A 2Uncertain (★★)+7: C1305Y at the same position is pathogenic; seen in 2e-06 of gnomAD DNA copies; REVEL 0.987

Which prediction tools work for Exudative vitreoretinopathy 4

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to Exudative vitreoretinopathy 4

Frequently asked questions

Which genes have records linked to Exudative vitreoretinopathy 4?

This view contains 1 analyzed proteins: LRP5. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 17 pathogenic or likely pathogenic variants, 179 variants of uncertain significance and 28 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 234 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center